Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000039

Director sold 250,000 shares at $5.28 ($1,320,000)

  • Director acquired 250,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nisi Rudolph Director 2014-01-29 Option exercise +50,000 $2.31 $115,500 53,500 D
Nisi Rudolph Director 2014-01-29 Option exercise +100,000 $1.18 $118,000 153,500 D
Nisi Rudolph Director 2014-01-29 Option exercise +50,000 $0.72 $36,000 203,500 D
Nisi Rudolph Director 2014-01-29 Option exercise +50,000 $1.71 $85,500 253,500 D
Nisi Rudolph Director 2014-01-29 Sale −250,000 $5.28 $1,320,000 3,500 D
Derivatives
Nisi Rudolph Director 2014-01-29 Option exercise · Stock Option (right to buy) −50,000 0 D
Nisi Rudolph Director 2014-01-29 Option exercise · Stock Option (right to buy) −100,000 0 D
Nisi Rudolph Director 2014-01-29 Option exercise · Stock Option (right to buy) −50,000 0 D
Nisi Rudolph Director 2014-01-29 Option exercise · Stock Option (right to buy) −50,000 0 D
Open-market sales · 250,000 sh · avg $5.28 · $1,320,000
Loading xslF345X03/primary_doc.xml…